Funding: Drug Company Sponsorship Makes For Less Critical Views, Researchers Say.

(Chicago)- Studies on the cost-effectiveness of drugs are far more likely to report favorable findings if they are sponsored by the drug companies themselves rather than independent groups, researcher5s found.

Their study - funded by a pharmaceutical company - appears to confirm long-held suspicions that doctors are less critical about a drug's safety and effectiveness when they have financial ties to the manufacturer.

"It is possible that these factors may result in some unconscious bias" in interpreting a study's findings, the researchers said.

[continues 446 words]